-
effectivehealthcare.ahrq.gov/sites/default/files/hunt_panel_3.pdf
January 01, 2010 - highest disease burden and
least access to health care resources
o Breathing Room— 18-‐ to 29-‐year
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/undescended-testicle_research-protocol.pdf
September 02, 2011 - Therefore, boys with suspected cryptorchidism often present very early in life,
often within the first year … In boys
under 1 year of age whose testicle is palpable and is close to, but not quite inside, the scrotum … In this case,
health care providers often elect to observe the patient’s condition until he is 1 year … Although about 70 percent of cryptorchid testes spontaneously descend within the first year
of life … We set a cut-off year of 1980 for all included publications.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/coronary-artery-disease-testing_research-protocol.pdf
January 15, 2015 - Each year, an estimated 1.5 percent of the population presents to primary care providers
with chest … predicted rate of cardiac mortality as described in the 2012
ACCF/AHA guideline: low risk (< 1% per year … ), intermediate risk (1% to 3% per year), or high
risk for cardiac mortality (> 3% per year).8 Clinical … inclusion, data will be abstracted into categories that
include but are not limited to: study design, year
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/urinary-incontinence-treatment_surveillance.pdf
October 29, 2012 - The follow up ranged from 4 weeks 6 to 1
year 7. … Particularly, moderate weight
loss reduced the incidence of UI at one year. … Diabetes Support
and Education (DSE)
(n= 1354;dose:NA)
1 year ILI + DSE
UI by amount of weight … lost at 1 year in women overall
Weekly incontinence by weight loss:
Per 1 kg [OR (95%CI)]: 0.97 ( … Control
59
Author year
Study name
(if applicable)
Study
design
Subjects
-
effectivehealthcare.ahrq.gov/sites/default/files/diabetes-update-2015_disposition-comments.pdf
January 01, 2015 - Efficacy
and tolerability of albiglutide versus placebo or
pioglitazone over 1 year inpeople with type … For the Executive Summary figures, we have
noted if the studies are 1 year or shorter or
provided the … exact range of study duration if the
studies are longer than 1 year. … One patient on dapagliflozin
10 mg was diagnosed with breast cancer within the
first year of enrollment … Most studies had adults with
diabetes in the 5-7 year range.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/atrial-fibrillation-ablation_surveillance.pdf
May 16, 2013 - Five-‐year
outcomes
after
segmental
pulmonary
vein
isolation
for
paroxysmal … termination
Source: www.effectivehealthcare.ahrq.gov
Published online: May 16, 2013
Author year … FU=36 mo)
Source: www.effectivehealthcare.ahrq.gov
Published online: May 16, 2013
Author year … Subjects
Treatment groups
(n; dose)
Treatment
duration
Outcomes and findings
to 1 year … AF that lasted from 1 week to 1 year:
25% vs. 36%, p=0.042
HR=1.45, 95% CI: 1.06, 1.98 [MVA]
(
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND-0520-131115.pdf
May 29, 2025 - )
More than 500,000 men and women die from CAD each year in the United States (US).
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/suicidal-thoughts-young-people-exe-sum.pdf
April 01, 2025 - approximately one in five high school students had seriously considered suicide at some
point over the prior year … suicidal events compared with enhanced usual
care (mostly involving individual therapy) over a four-year … Youth
Suicide During the First Year of the
COVID-19 Pandemic. … Association of the Youth-Nominated
Support Team Intervention for Suicidal
Adolescents With 11- to 14-Year
-
effectivehealthcare.ahrq.gov/sites/default/files/masks-appendix-table-b-2-version-2.xlsx
January 01, 2007 - Observational studies of masks in the community
Author Publication Year Title Date Retrieved Source
-
effectivehealthcare.ahrq.gov/sites/default/files/renal-cancer_disposition-comments.pdf
February 24, 2016 - For example a new baseline
GFR of 50 for a 75 year old male may not be an issue, 57 year old
male ( … median age of diagnosis for RCC) who has a 20 year life
expectancy otherwise may certainly be. … studies reporting these
subgroups and outcomes, and the few studies
reporting follow-up beyond one year … analysis is limited by power and by
limited data on long-term renal functional
outcomes (beyond 1 year … RCC incidence is a well-
documented phenomenon, demonstrating an
increase in incidence of 2-3% per year
-
effectivehealthcare.ahrq.gov/system/files/docs/topic-brief-apbi-breast-cancer.pdf
August 01, 2022 - QOL After APBI (Multicatheter Brachytherapy) Versus WBI: 5-
Year Results, Phase 3 GEC-ESTRO Trial. … versus whole-breast irradiation in early breast cancer
after breast-conserving surgery (GEC-ESTRO): 5-year … Seven-Year Outcomes Following Accelerated Partial
Breast Irradiation Stratified by ASTRO Consensus Groupings … after
breast-conserving surgery for low-risk invasive and in-situ carcinoma of the female breast: 5-
year … As measured in 2016, costs in the year after
diagnosis for all stages of breast cancer ranged
from
-
effectivehealthcare.ahrq.gov/sites/default/files/masks-surveillance-2-appendix-table-a-1.xlsx
April 09, 2020 - Randomized controlled trials of mask use
Author
Registry # Publication Year Title Date Retrieved Source … to 1.01)
Doctor vs. nurse: 58.9% (201/341) vs. 55.7% (450/808), RR 1.06 (95% CI 0.95 to 1.18)
Work year … C
Influenza vaccination in 2008 (year of study): 9.5% vs. 21.5% vs. 22.2%; p<0.01
Influenza vaccination … in 2007 (year prior to study): 14.8% vs. 21.5% vs. 22.2%; p<0.01
Doctor: 36.0% vs. 29.5% vs. 31.1%; … C
Seasonal influenza vaccination in 2009-2010 (year of study): 14.6% vs. 9.9% vs. 15.4%; p=0.017
A(H1N1
-
effectivehealthcare.ahrq.gov/sites/default/files/masks-appendix-table-b-1-version-2.xlsx
April 09, 2020 - Randomized controlled trials of mask use
Author
Registry # Publication Year Title Date Retrieved Source … to 1.01)
Doctor vs. nurse: 58.9% (201/341) vs. 55.7% (450/808), RR 1.06 (95% CI 0.95 to 1.18)
Work year … C
Influenza vaccination in 2008 (year of study): 9.5% vs. 21.5% vs. 22.2%; p<0.01
Influenza vaccination … in 2007 (year prior to study): 14.8% vs. 21.5% vs. 22.2%; p<0.01
Doctor: 36.0% vs. 29.5% vs. 31.1%; … C
Seasonal influenza vaccination in 2009-2010 (year of study): 14.6% vs. 9.9% vs. 15.4%; p=0.017
A(H1N1
-
effectivehealthcare.ahrq.gov/sites/default/files/Masks-appendix-table-b-1-surveillance-report.xlsx
April 09, 2020 - Randomized controlled trials of mask use
Author
Registry # Publication Year Title Date Retrieved Source … to 1.01)
Doctor vs. nurse: 58.9% (201/341) vs. 55.7% (450/808), RR 1.06 (95% CI 0.95 to 1.18)
Work year … C
Influenza vaccination in 2008 (year of study): 9.5% vs. 21.5% vs. 22.2%; p<0.01
Influenza vaccination … in 2007 (year prior to study): 14.8% vs. 21.5% vs. 22.2%; p<0.01
Doctor: 36.0% vs. 29.5% vs. 31.1%; … C
Seasonal influenza vaccination in 2009-2010 (year of study): 14.6% vs. 9.9% vs. 15.4%; p=0.017
A(H1N1
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/masks-appendix-table-b-1-version-1.xlsx
April 09, 2020 - Randomized controlled trials of mask use
Author
Registry # Publication Year Title Date Retrieved Source … to 1.01)
Doctor vs. nurse: 58.9% (201/341) vs. 55.7% (450/808), RR 1.06 (95% CI 0.95 to 1.18)
Work year … C
Influenza vaccination in 2008 (year of study): 9.5% vs. 21.5% vs. 22.2%; p<0.01
Influenza vaccination … in 2007 (year prior to study): 14.8% vs. 21.5% vs. 22.2%; p<0.01
Doctor: 36.0% vs. 29.5% vs. 31.1%; … C
Seasonal influenza vaccination in 2009-2010 (year of study): 14.6% vs. 9.9% vs. 15.4%; p=0.017
A(H1N1
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/mhs-IV-surgical-report-cards.pdf
July 01, 2023 - A 1998 study
estimated that over 40-50 million operations are performed in the USA each year in
hospital … • No outcome of interest
Timing Original studies published from
2011 onwards, the year of the … a single team member to confirm eligibility and prepare a summary of
the study, including author, year … describe eligible systematic reviews, a single team member will prepare a summary
including the author, year
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/copd-anticholinergic-medicines_research.pdf
December 01, 2009 - Fourth, follow-up was
stopped after 365 days to evaluate results over a one-year period. … This was a
four year, multinational, randomized controlled trial that compared tiotropium to placebo … A 4-
year trial of tiotropium in chronic
obstructive pulmonary disease. … A 4-
year trial of tiotropium in chronic
obstructive pulmonary disease. … A 4-
year trial of tiotropium in chronic
obstructive pulmonary disease.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/vaccines-safety-protocol-130325.pdf
September 18, 2012 - costs of influenza infection alone in adults are have been estimated to be as high as
$87 billion per year
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/renal-cancer_research-protocol.pdf
April 20, 2015 - resected tumors.[1, 3] It is known that
kidney cancer affects approximately 65,000 new patients each year … stage T1N0M0, ≤ 7 cm in
diameter; stage T2N0M0, > 7 cm in diameter) have excellent outcomes with 5-year … All
extirpative options are associated with an excellent oncologic cure rate (> 95% 5-year disease … Clavien, P.A., et al., The Clavien-Dindo classification of surgical complications: five-
year experience … uncontrolled study will
get listed in the appendix with the
following data:
Author, publication year
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/home-based-care_research-protocol.pdf
November 19, 2014 - inclusion, data will be abstracted into categories that
include but are not limited to: study design, year